Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis.
Julette Marie F BataraAlmira Doreen Abigail O AporChristianne V MojicaMark Willy L MondiaPublished in: Neuro-oncology advances (2022)
Rituximab, temozolomide, and radiotherapy can be considered as an effective and safe salvage therapy for relapsed and recurrent central nervous system lymphoma.